Methicillin Resistant Staphylococcus aureus Endocarditis in an Australian Tertiary Hospital: 1991-2006

Heart Lung and Circulation

Volumn 18, Issue 3, 2009, Pages 208-213

  Rogers, Benjamin A ^a   Drake, Anne K ^b   Spelman, Denis ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

Australia; Bacterial; Cross infection; Endocarditis; Methicillin resistance; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; FUSIDIC ACID; IMMUNOSUPPRESSIVE AGENT; LINEZOLID; METICILLIN; RIFAMPICIN; VANCOMYCIN;

ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; BACTEREMIA; BACTERIAL ENDOCARDITIS; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COMMUNICABLE DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMBOLISM; FEMALE; HEART ABSCESS; HEART VALVE PROSTHESIS; HEART VALVE REGURGITATION; HEMODIALYSIS; HOSPITAL INFECTION; HUMAN; INTRAVENOUS DRUG ABUSE; MALE; MALIGNANT NEOPLASTIC DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROSTHETIC VALVE ENDOCARDITIS; RETROSPECTIVE STUDY; SURVIVAL; TERTIARY HEALTH CARE; TREND STUDY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; VICTORIA;

EID: 67349267812     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2008.10.016     Document Type: Article

References (26)

1. Cabell C.H., Jollis J.G., Peterson G.E., Corey G.R., Anderson D.J., Sexton D.J., Woods C.W., Reller L.B., Ryan T., and Fowler Jr. V.G. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 162 January (1) (2002) 90-94
2. Cheng A., Athan E., Appelbe A., and McDonald M. The changing profile of bacterial endocarditis as seen at an Australian provincial centre. Heart Lung Circ 11 (2002) 26-31
3. Chang F.-Y., MacDonald B.B., Peacock Jr. J.E., Musher D.M., Triplett P., Mylotte J.M., O'Donnell A., Wagener M.M., and Yu V.L. A prospective multicenter study of Staphylococcus aureus Bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 82 September (5) (2003) 322-332
4. Miro J.M., Anguera I., Cabell C.H., Chen A.Y., Stafford J.A., Corey G.R., Olaison L., Eykyn S., Hoen B., Abrutyn E., Raoult D., Bayer A., Fowler Jr. V.G., and International Collaboration on Endocarditis Merged Database Study G. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 41 August (4) (2005) 507-514
5. Fowler Jr. V.G., Miro J.M., Hoen B., Cabell C.H., Abrutyn E., Rubinstein E., Corey G.R., Spelman D., Bradley S.F., Barsic B., Pappas P.A., Anstrom K.J., Wray D., Fortes C.Q., Anguera I., Athan E., Jones P., van der Meer J.T., Elliott T.S., Levine D.P., Bayer A.S., and Investigators I.C.E. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293 24 (2005) 3012-3021
6. Li J.S., Sexton D.J., Mick N., Nettles R., Fowler Jr. V.G., Ryan T., Bashore T., and Corey G.R. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30 (2000) 633-638
7. Cabell C.H., and Abrutyn E. Progress toward a global understanding of infective endocarditis: early lessons from the International Collaboration on Endocarditis investigation. Infect Dis Clin North Am 16 2 (2002) 255-272
8. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., Lamm W., Clark C., MacFarquhar J., Walton A.L., Reller L.B., and Sexton D.J. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137 10 (2002) 791-797
9. Libman H., and Arbeit R.D. Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med 144 3 (1984) 541-545
10. Dwyer D.E., Chen S.C., Wright E.J., Crimmins D., Collignon P.J., and Sorrell T.C. Hospital practices influence the pattern of infective endocarditis. Med J Aust 160 11 (1994) 709-713
11. Howden B.P., Ward P.B., Charles P.G., Korman T.M., Fuller A., du Cros P., Grabsch E.A., Roberts S.A., Robson J., Read K., Bak N., Hurley J., Johnson P.D., Morris A.J., Mayall B.C., and Grayson M.L. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 38 4 (2004) 521-528
12. Bouza E., Menasalvas A., Munoz P., Vasallo F.J., Moreno M.D.M., and Fernandez M.A.G. Infective endocarditis-a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore) 80 5 (2001) 298-307
13. Netzer R.O., Zollinger E., Seiler C., and Cerny A. Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980-1995. Heart 84 1 (2000) 25-30
14. Hogevik H., Olaison L., Andersson R., Lindberg J., and Alestig K. Epidemiologic aspects of infective endocarditis in an urban population: a 5-year prospective study. Medicine (Baltimore) 74 6 (1995, Nov) 324-339
15. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., and Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39 3 (2004) 309-317
16. Sherwood M.B.S., Smith D.B.S., Crisel R.B.S.E., Veledar E.P., and Lerakis S.M.D. Staphylococcus aureus endocarditis: the Grady Memorial Hospital Experience. Am J Med Sci 331 2 (2006) 84-87
17. Collignon P., Nimmo G.R., Gottlieb T., and Gosbell I.B. Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis 11 4 (2005) 554-561
18. Hsu R.B., and Chu S.H. Impact of methicillin resistance on clinical features and outcomes of infective endocarditis due to Staphylococcus aureus. Am J Med Sci 328 3 (2004, Sep) 150-155
19. Therapeutic Guidelines: antibiotic. 5th ed. North Melbourne, Victoria: Therapeutic Guidelines Limited, 1987.
20. Baddour L.M., Wilson W.R., Bayer A.S., Fowler Jr. V.G., Bolger A.F., Levison M.E., Ferrieri P., Gerber M.A., Tani L.Y., Gewitz M.H., Tong D.C., Steckelberg J.M., Baltimore R.S., Shulman S.T., Burns J.C., Falace D.A., Newburger J.W., Pallasch T.J., Takahashi M., and Taubert K.A. Committee on Rheumatic Fever E, Kawasaki D, Council on Cardiovascular Disease in the Y, Councils on Clinical Cardiology S, Cardiovascular S, Anesthesia, American Heart A, Infectious Diseases Society of A. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111 23 (2005) e394-434
21. Horstkotte D., Follath F., Gutschik E., Lengyel M., Oto A., Pavie A., Soler-Soler J., Thiene G., von Graevenitz A., Priori S.G., Garcia M.A., Blanc J.J., Budaj A., Cowie M., Dean V., Deckers J., Fernandez Burgos E., Lekakis J., Lindahl B., Mazzotta G., Morais J., Smiseth O.A., Vahanian A., Delahaye F., Parkhomenko A., Filipatos G., Aldershvile J., and Vardas P. Task Force Members on Infective Endocarditis of the European Society of C, Guidelines ESCCfP, Document R. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 25 3 (2004) 267-276
22. Lodise T.P., McKinnon P.S., Swiderski L., and Rybak M.J. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 36 11 (2003, Jun 1) 1418-1423
23. Levine D.P., Cushing R.D., Jui J., and Brown W.J. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the detroit medical centre. Ann Intern Med 97 (1982) 330-338
24. Nimmo G.R., Bell J.M., Mitchell D., Gosbell I.B., Pearman J.W., Turnidge JD, and on behalf of the AGAR. Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989-1999. Microb Drug Resist 9 2 (2003) 155-160
25. Nimmo G., Pearson J.C., Collignon P., Christiansen K.J., Coombs G.W., Bell J.M., and McLaws M.L. Prevalence of MRSA among Staphylococcus Aureus isolated from hospital inpatients, 2005: report from The Australian Group for antimicrobial resistance. Commun Dis Intell 31 3 (2007) 288-296
26. Drees M.A.B., and Boucher A.A. New agents for Staphylococcus aureus endocarditis. Curr Opin Infect Dis 19 6 (2006) 544-550